The results demonstrated that CD302 expression was significantly upregulated in A549 and PC-9 cells in the overexpression group compared to the control group (Figures 6C, D), indicating the successful establishment of the CD302-overexpressing NSCLC cell model. This evidence concerns the gene CD302 and non-small cell lung carcinoma.